BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2020
View Archived Issues
Telix cleared to begin first-in-human study of TLX-592 for prostate cancer
Read More
Deglycosylated receptor-binding domain recombinant proteins as scalable SARS-CoV candidates
Read More
Novel Nav1.7 channel inhibitor with potent analgesic activity in a mouse model of neuropathic pain
Read More
First patient dosed in phase I study of FS-120
Read More
Positive interim data from phase II study of Allocetra in severe and critical COVID-19
Read More
Updated data presented from ongoing DeCidE1 study of DPX-Survivac
Read More
Chugai describes antigen-binding molecules targeting C1s
Read More
Initiation of phase I study of QPX-7728 for drug-resistant bacterial infections
Read More
Positive data from GLP toxicology study of EYP-1901
Read More
Sirnaomics to start phase I trial of STP-705 in liver cancer
Read More
Zhejiang Hisun Pharmaceutical, Shanghai Aryl Pharmtech describe AGTR2 antagonists
Read More
New EGFR inhibitors discovered at Zhejiang University
Read More
Henan Zhiwei Biomedicine, Henan Normal University present new BTK inhibitors
Read More
GEMoaB begins first-in-human study of UniCAR-T-PSMA
Read More
Yangtze River Pharmaceutical, Shanghai Haiyan Pharmaceutical Technology patent PD-1/PD-L1 inhibitors
Read More
FDA accepts IND application for MicroLine as treatment of presbyopia
Read More
Serotonin found to differentially promote patience
Read More
Small molecule TNF-alpha inhibitors from UCB Pharma display efficacy in arthritis models
Read More
Phase III study of masitinib in first-line pancreatic cancer with pain shows survival increase
Read More
Sotagliflozin data presented in patients with type 2 diabetes with cardiac or renal complications
Read More
FDA approves oral once-daily Orladeyo to prevent HAE attacks
Read More
CV outcomes from FIDELIO-DKD trial of finerenone in patients with CKD and T2D
Read More
New phase II trial investigates silmitasertib for moderate COVID-19
Read More
Ascletis advances envafolimab into phase IIb for chronic hepatitis B
Read More
Researchers develop a feline model of heart failure with preserved eject fraction
Read More
Clover reports phase I data on adjuvanted S-Trimer COVID-19 vaccine candidates
Read More
Tevard and Zogenix collaborate on novel tRNA-based gene therapies for genetic epilepsies
Read More
